Crinetics Pharmaceuticals, Inc. Profile Avatar - Palmy Investing

Crinetics Pharmaceuticals, Inc.

Crinetics Pharmaceuticals, Inc., a clinical stage pharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for rare endocrine diseases and endocrine-related tumors. Its lead product candidate is Paltusotine, an…

Biotechnology
US, San Diego [HQ]
Strategy & Leadership

Officers & BofD Beta

  • Form 3/4/5
  • Proxy DEF-14A

Total Compensation

- No data, only available if we have DEF 14A compensations in place -
Officers
Name & Position Research Last Appearance
- No data available -
Board of Directors (BofD)
Name & Position Research Last Appearance
- No data available -
End of CRNX's Analysis
CIK: 1658247 CUSIP: 22663K107 ISIN: US22663K1079 LEI: - UEI: -
Secondary Listings
CRNX has no secondary listings inside our databases.